Ignite Creation Date:
2024-05-06 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05029999
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2021-08-25
Brief Title:
CD40 Agonist Flt3 Ligand and Chemotherapy in HER2 Negative Breast Cancer
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04-20
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-25
First Submit QC Date:
August 25 2021
Study First Post Date:
2021-09-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL